The atypical PKC scaffold protein P62 is a novel target for anti-inflammatory and anti-cancer therapies.

TitleThe atypical PKC scaffold protein P62 is a novel target for anti-inflammatory and anti-cancer therapies.
Publication TypeJournal Article
Year of Publication2002
AuthorsMoscat J, Diaz-Meco MT
JournalAdv Enzyme Regul
Volume42
Pagination173-9
Date Published2002
ISSN0065-2571
KeywordsAnimals, Antineoplastic Agents, Carrier Proteins, Humans, Lipid Metabolism, MAP Kinase Kinase 5, Mitogen-Activated Protein Kinase Kinases, Models, Biological, Nerve Growth Factor, NF-kappa B, Protein Binding, Protein Isoforms, Protein Kinase C, Protein Structure, Tertiary, Signal Transduction, Tumor Cells, Cultured, Zinc
DOI10.1016/s0065-2571(01)00029-2
Alternate JournalAdv Enzyme Regul
PubMed ID12123714
Related Faculty: 
Jorge Moscat, Ph.D. Maria Diaz-Meco Conde, Ph.D.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700